Welcome to our dedicated page for Maximus news (Ticker: MMS), a resource for investors and traders seeking the latest updates and insights on Maximus stock.
Maximus, Inc. reports developments tied to its role as a provider of tech-enabled government services for public programs. The company supports government agencies with business process management, technology solutions, health insurance eligibility and enrollment programs, clinical services, assessments, appeals and independent medical reviews across U.S. Federal Services, U.S. Services and international operations.
Recurring news includes fiscal results, guidance updates, sales-pipeline commentary, segment trends, clinical program demand and productivity initiatives. Company updates also cover AI-enabled tools such as Accuracy Assistant for state SNAP programs, quarterly cash dividends, common-stock repurchase authorizations and governance changes involving senior legal and corporate-secretary roles.
Maximus (NYSE: MMS) reported FY2026 Q2 results: revenue of $1.31B, diluted EPS of $1.80 and adjusted diluted EPS of $2.07. The company raised full-year adjusted EBITDA margin by 20 bps to ~14.2% and raised adjusted diluted EPS guidance by $0.20 to $8.25–$8.55.
The Board refreshed a share repurchase authorization up to $400M; Q2 repurchases totaled ~1.4M shares for $111M plus 0.6M shares for $39.9M through May 1, 2026. A quarterly cash dividend of $0.33 is payable June 1, 2026.
Maximus (NYSE: MMS) named Elizabeth Moellering as General Counsel and Corporate Secretary, effective April 24, 2026. Moellering served as Interim General Counsel and Deputy General Counsel since February 2026 and joined Maximus in 2024 as Head of Litigation.
Her background includes litigation roles at Optum, federal prosecution on white‑collar and child victim cases, and private practice at Skadden Arps.
Maximus (NYSE: MMS) will release financial results for the three and six months ended March 31, 2026, on May 7, 2026 at 6:30 a.m. ET and will host a public conference call the same day at 9:00 a.m. ET.
The call is available by webcast and phone (Domestic: 877.407.8289; International: +1.201.689.8341), and a recording will be posted at investor.maximus.com.
Maximus (NYSE: MMS) declared a quarterly cash dividend of $0.33 per share, payable on June 1, 2026 to shareholders of record on May 15, 2026. This distribution reflects a board-approved cash payout for common shareholders, with ex‑dividend implied before the record date.
Spire Global (NYSE: SPIR) appointed John Martinez to its board of directors, effective March 9, 2026. Martinez is chief legal officer at Parsons and previously served as chief legal officer at Maximus, bringing more than two decades of government, defense, and intelligence sector experience to Spire.
The appointment underscores Spire's focus on expanding sovereign-ready space intelligence for U.S. and allied partners.
Maximus (NYSE: MMS) reported Q1 FY2026 results for quarter ended December 31, 2025: revenue $1.35B, diluted EPS $1.70, and adjusted diluted EPS $1.85. The company narrowed revenue guidance to $5.2B–$5.35B, raised adjusted diluted EPS guidance to $8.05–$8.35, and increased adjusted EBITDA margin to ~14%. A quarterly cash dividend of $0.33 is payable March 2, 2026.
Cash used in operations was $244M and free cash flow was an outflow of $251M; sales pipeline totaled $59.1B.
Maximus (NYSE: MMS) launched Accuracy Assistant, an AI-enabled suite for state SNAP programs that uses predictive analytics, intelligent automation, and NLP to identify data inconsistencies and flag high-risk cases in real time before benefits are issued. The tool offers eligibility inconsistency detection, side-by-side staff support with policy guidance, auto-generated interaction summaries, and interactive dashboards for monitoring. The launch is timed ahead of federal SNAP changes requiring states to fund a portion of benefits starting October 2027 when state payment error rates exceed 6%. Maximus positions the product as a preventative quality-assurance solution to reduce error rates and strengthen program integrity.
Maximus (NYSE: MMS) will release fiscal 2026 first quarter results for the three months ended December 31, 2025 on Thursday, February 5, 2026 at 6:30 a.m. ET. The company will host a public conference call the same day at 9:00 a.m. ET, accessible by webcast and by phone at 877.407.8289 (Domestic) or +1.201.689.8341 (International). A recording of the webcast will be available afterward at investor.maximus.com.
Maximus (NYSE: MMS) announced a quarterly cash dividend of $0.33 per share, a 10% increase from the prior quarterly dividend of $0.30.
The Board approved the dividend payable on March 2, 2026 to shareholders of record on February 13, 2026. Management said the increase reflects recent earnings growth and the company’s disciplined capital deployment strategy.
Maximus (NYSE: MMS) reported fiscal 2025 results with $5.43B revenue, up 2.4% year-over-year and 3.9% organic growth driven by U.S. Federal clinical programs. Fiscal operating margin expanded to 9.7% and adjusted EBITDA margin to 12.9%. Adjusted diluted EPS was $7.36 and free cash flow totaled $366M. The company repurchased ~5.8M shares for $456.6M and ended the year with net leverage of 1.5x. Management declared a quarterly dividend of $0.30 per share payable Dec 1, 2025. For fiscal 2026, Maximus provided guidance: revenue of $5.225B–$5.425B, adjusted EBITDA margin ~13.7%, adjusted diluted EPS $7.95–$8.25, and free cash flow $450M–$500M.